Endocrine and metabolic aspects of the COVID-19 pandemic
Top Cited Papers
- 9 July 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Reviews in Endocrine and Metabolic Disorders
- Vol. 21 (4), 495-507
- https://doi.org/10.1007/s11154-020-09569-2
Abstract
COVID-19 infection has tremendously impacted our daily clinical practice as well as our social living organization. Virtually all organs and biological systems suffer from this new coronavirus infection, either because the virus targets directly specific tissues or because of indirect effects. Endocrine diseases are not an exception and some of endocrine organs are at risk of direct or indirect lesion by COVID-19. Although there is still no evidence of higher predisposition to contract the infection in patients with diabetes and/or obesity, the coexistence of these conditions contributes to a worse prognosis because both conditions confer an impaired immunologic system. Cytokines storm can be amplified by these two latter conditions thereby leading to multisystemic failure and death. Glycaemic control has been demonstrated to be crucial to avoiding long hospital stays, ICU requirement and also prevention of excessive mortality. Endocrine treatment modifications as a consequence of COVID-19 infection are required in a proactive manner, in order to avoid decompensation and eventual hospital admission. This is the case of diabetes and adrenal insufficiency in which prompt increase of insulin dosage and substitutive adrenal steroids through adoption of the sick day’s rules should be warranted, as well as easy contact with the health care provider through telematic different modalities. New possible endocrinological targets of COVID-19 have been recently described and warrant a full study in the next future.Keywords
This publication has 114 references indexed in Scilit:
- Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMCNature, 2013
- Infections in patients with diabetes mellitus: A review of pathogenesisIndian Journal of Endocrinology and Metabolism, 2012
- Hospitalized Patients With 2009 H1N1 Influenza Infection: The Mayo Clinic ExperienceMayo Clinic Proceedings, 2010
- Tratamiento de la hiperglucemia en el hospitalMedicina Clinica, 2009
- Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate CancerScience, 2005
- Hypocortisolism in survivors of severe acute respiratory syndrome (SARS)Clinical Endocrinology, 2005
- Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2Cell Metabolism, 2005
- Lipid disorders in antiretroviral-naive patients treated with lopinavir/ritonavir-based HAART: frequency, characterization and risk factorsJournal of Antimicrobial Chemotherapy, 2005
- Molecular mimicry of ACTH in SARS – implications for corticosteroid treatment and prophylaxisMedical Hypotheses, 2004
- Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirusNature, 2003